Sirtris Pharmaceuticals
A company developing small molecule drugs to treat aging and metabolic diseases such as type 2 diabetes
4
Funding Rounds
$82.0m
Money raised
Overview
A company developing small molecule drugs to treat aging and metabolic diseases such as type 2 diabetes
-
Website:
Funding
Funding series
Funding Series Analysis
The company Sirtris Pharmaceuticals has raised a total of $82m in funding over 4 rounds.
Key Insights:
- Sirtris Pharmaceuticals Series C round: $37m
- Sirtris Pharmaceuticals Series B round: $27m
- Sirtris Pharmaceuticals Series A round: $13m
- Sirtris Pharmaceuticals seed round: $5m
Sirtris Pharmaceuticals Series C round
$37m
Sirtris Pharmaceuticals Series B round
$27m
Sirtris Pharmaceuticals Series A round
$13m
Sirtris Pharmaceuticals seed round
$5m
Industries
Sirtris Pharmaceuticals is active in the following industries: